Lubiprostone M14 Metabolite

METABOLITES

Product Details

CAT No.# CS-P-02288
Category Metabolites
CAS 1246812-13-4
Molecular Weight 366.35
Synonyms: (6R)-8-[(1R,2R,5R)-2-(2-carboxyethyl)-5-hydroxy-3-oxocyclopentyl]-5,5-difluoro-6-hydroxyoctanoic acid
Application Notes: Metabolite of Lubiprostone
Shipping: Free Shipping for worldwide on order above 2000 USD
COA:    View COA
Lubiprostone M14 Metabolite Worldwide Suppliers of Lubiprostone M14 Metabolite Metabolites Clearsynth CS-P-02288

Product rating: 9 Lubiprostone M14 Metabolite based on 20 ratings

  1. Metabolites
  2. Lubiprostone M14 Metabolite

PEOPLE ALSO SEARCHED FOR: 1. propan-2-yl-5-hydroxy-2-methyl-2-4-(3-nitrophenyl)-6-oxo-1,4,5,5-tetraahydropyridine-3-carboxylate
2. ([13C6]Leu5)-Ghrelin (human) (H-7252.1000)
3. Lauroside D
4. Triazolam 13C D3
5. Icatibant impurity 1
6. BISPHENOL AF (RING-13C12)
7. 0.1% TFA in Water ULC-MS
8. Metamizole EP Impurity C HCl
9. Silodosin Metabolite D4
10. Silodosin Metabolite
11. 2-Phenoxymethanesulfonanilide
12. Nimesulide EP Impurity A
13. Acetone HPLC
14. Nandrolone Decanoate EP impurity F
15. N-(4-Bromophenyl)-3-methyl-N-(m-tolyl)aniline
16. Ortho toluene sulfonic acid
17. Sucrose (1623637)
18. Crisaborole m-Isomer
19. Riluzole (1604337)
20. Pheniramine impurity B




This page contains information about Lubiprostone M14 Metabolite Cas 1246812-13-4 and its Metabolites.

Lubiprostone M14 Metabolite Lubiprostone M14 Metabolite Worldwide Suppliers of Lubiprostone M14 Metabolite Metabolites Clearsynth 1246812-13-4

"Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk."